Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?

During the past two decades, the unequivocally recommended treatment method of Type 2 diabetes mellitus was insulin administration and intensification in the earliest possible stage of the diagnosis. This approach is not only unfounded but was never scientifically proven. Yet, it has been zealously...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shmuel Levit, Shmuel Giveon, Yury I. Philippov, Ivan Panchev Domuschiev, Amir Zivony
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2016
Materias:
Acceso en línea:https://doaj.org/article/4f28a807bb1f4ba0a7dd7c07b01656d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4f28a807bb1f4ba0a7dd7c07b01656d6
record_format dspace
spelling oai:doaj.org-article:4f28a807bb1f4ba0a7dd7c07b01656d62021-11-14T09:00:20ZType 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?2072-03512072-037810.14341/DM7077https://doaj.org/article/4f28a807bb1f4ba0a7dd7c07b01656d62016-11-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7077https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378During the past two decades, the unequivocally recommended treatment method of Type 2 diabetes mellitus was insulin administration and intensification in the earliest possible stage of the diagnosis. This approach is not only unfounded but was never scientifically proven. Yet, it has been zealously advocated to medical professionals. In fact, a sound body of evidence disproves this long-standing treatment approach. This method is a cornerstone of, what we now know to be two great illusions of past century, namely, glucocentrism and intensification. Numerous recently published studies provide alarming data regarding serious side effects of blind intensification and insulin overdosing in T2DM. They raise major concerns and call for revision of the traditional approach. Since insulin is an integral and deeply rooted part of the intensification agenda of treating T2DM, it has now suffered a serious drawback. Alternatively, in this review authors present the novel Gravicentric (Energy) concept of T2DM acceptance and therapy. They offer a new classification of anti-diabetes drugs based on their energy effect and present their Gravicentric Algorithm for wide practical utilization. For that reason, the "ELEPHANT" abbreviation was found as a helpful reminder. Viewing T2DM as disease of energy balance together with anti – energy drugs implementation provide medical doctors an unique opportunity to transform T2DM from "slowly – progressive" disease to rapidly reversible condition, which it actually is.Shmuel LevitShmuel GiveonYury I. PhilippovIvan Panchev DomuschievAmir ZivonyEndocrinology Research Centrearticlediabetes type 2gravicentricenergy-wastingenergy-sparingcalorieinsulinintensificationde-intensificationalgorithmcardiovascularcancerbody mass indexNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 4, Pp 341-349 (2016)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes type 2
gravicentric
energy-wasting
energy-sparing
calorie
insulin
intensification
de-intensification
algorithm
cardiovascular
cancer
body mass index
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes type 2
gravicentric
energy-wasting
energy-sparing
calorie
insulin
intensification
de-intensification
algorithm
cardiovascular
cancer
body mass index
Nutritional diseases. Deficiency diseases
RC620-627
Shmuel Levit
Shmuel Giveon
Yury I. Philippov
Ivan Panchev Domuschiev
Amir Zivony
Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
description During the past two decades, the unequivocally recommended treatment method of Type 2 diabetes mellitus was insulin administration and intensification in the earliest possible stage of the diagnosis. This approach is not only unfounded but was never scientifically proven. Yet, it has been zealously advocated to medical professionals. In fact, a sound body of evidence disproves this long-standing treatment approach. This method is a cornerstone of, what we now know to be two great illusions of past century, namely, glucocentrism and intensification. Numerous recently published studies provide alarming data regarding serious side effects of blind intensification and insulin overdosing in T2DM. They raise major concerns and call for revision of the traditional approach. Since insulin is an integral and deeply rooted part of the intensification agenda of treating T2DM, it has now suffered a serious drawback. Alternatively, in this review authors present the novel Gravicentric (Energy) concept of T2DM acceptance and therapy. They offer a new classification of anti-diabetes drugs based on their energy effect and present their Gravicentric Algorithm for wide practical utilization. For that reason, the "ELEPHANT" abbreviation was found as a helpful reminder. Viewing T2DM as disease of energy balance together with anti – energy drugs implementation provide medical doctors an unique opportunity to transform T2DM from "slowly – progressive" disease to rapidly reversible condition, which it actually is.
format article
author Shmuel Levit
Shmuel Giveon
Yury I. Philippov
Ivan Panchev Domuschiev
Amir Zivony
author_facet Shmuel Levit
Shmuel Giveon
Yury I. Philippov
Ivan Panchev Domuschiev
Amir Zivony
author_sort Shmuel Levit
title Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
title_short Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
title_full Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
title_fullStr Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
title_full_unstemmed Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
title_sort type 2 diabetes therapeutic strategies: why don't we see the «elephant» in the room?
publisher Endocrinology Research Centre
publishDate 2016
url https://doaj.org/article/4f28a807bb1f4ba0a7dd7c07b01656d6
work_keys_str_mv AT shmuellevit type2diabetestherapeuticstrategieswhydontweseetheelephantintheroom
AT shmuelgiveon type2diabetestherapeuticstrategieswhydontweseetheelephantintheroom
AT yuryiphilippov type2diabetestherapeuticstrategieswhydontweseetheelephantintheroom
AT ivanpanchevdomuschiev type2diabetestherapeuticstrategieswhydontweseetheelephantintheroom
AT amirzivony type2diabetestherapeuticstrategieswhydontweseetheelephantintheroom
_version_ 1718429525653585920